Related Experiment Video
Updated: Aug 6, 2026
14:28
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function
1Institut du Cancer et d'Immunogénétique, Villejuif, France.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1991
Summary
Bestatin is an immuno-modifier that stimulates immune cells and can restore immune function. It also shows potential in preventing tumors and aiding in addiction recovery.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- Bestatin is a dipeptide that inhibits leucine aminopeptidase and aminopeptidase B.
- It modulates immune responses through direct and indirect mechanisms.
- Previous studies have indicated its potential as an immuno-modifier.
Purpose of the Study:
- To investigate the immunomodulatory effects of Bestatin.
- To evaluate its potential as an immunorestorative agent in various conditions.
- To explore its role in tumor prevention and addiction treatment.
Main Methods:
- In vitro and in vivo studies were conducted.
- Bestatin's effects on lymphocytes, monocytes, granulocytopoiesis, and thrombocytopoiesis were assessed.
- Its impact on tuftsin catabolism and enkephalin protection was examined.
Main Results:
- Bestatin demonstrated direct stimulation of lymphocytes and monocytes.
- It acted as an immuno-modifier in young mice and an immunorestorative agent in aged mice.
- The compound showed potential in restoring immune function in elderly individuals, cancer patients, and HIV-infected subjects.
- Bestatin stimulated granulocytopoiesis and thrombocytopoiesis in vitro and restored them in vivo.
- Preliminary results suggest analgesic action and a preventive effect on toxicomaniac relapses.
Conclusions:
- Bestatin is a potent immuno-modifier with broad therapeutic potential.
- It can restore immune function and prevent spontaneous tumors.
- Further research is warranted for its application in pain management and addiction treatment.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
10:26Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
Related Concept Videos
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:19Allosteric Proteins-ATCase
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...